Memorial Sloan Kettering Cancer Center
Lymphoma
Memorial Sloan Kettering Cancer Center
Key Lymphoma Updates From ASH
FEATURING
Pallawi Torka
- 372 views
- May 2, 2024
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: What Is High Risk MCL and How Should We Treat It
FEATURING
Anita Kumar
- 192 views
- October 18, 2023
- 1
MedNews Week
The Evolving 1L DLBCL Landscape: POLARIX, Novel Agents and Future Directions
FEATURING
Matthew Matasar
- 288 views
- August 8, 2023
- 1
MedNews Week
Current Management of Newly Diagnosed DLBCL
FEATURING
Matthew Matasar
- 43 views
- August 8, 2023
SOHO Brazil 2023
2023 SOHO® Brazil: "Moving Beyond CHOP/CHOEP - How Disease Features Can Guide Treatment in T-Cell Lymphomas"
FEATURING
Alison Moskowitz
- 85 views
- August 3, 2023
- 1
Indy Hematology Review
Managing Indolent and Mantle Cell Lymphomas With Targeted and Cellular Therapies in 2023
FEATURING
Gilles Salles
- 154 views
- April 18, 2023
- 1
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: The Next Wave of Novel Agents in Aggressive B-Cell Lymphoma
FEATURING
Gilles Salles
- 22 views
- September 30, 2021
i3 Health
MSKCC 2021 Update on Therapeutic Advances in T-Cell Lymphoma: Subtypes, Novel Therapies, and AEs Management Strategies
FEATURING
Steven Horwitz
- 142 views
- August 3, 2021
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on DLBCL: CAR-T vs. autoHCT for Early Relapsed Disease and PET+ Sensitive Pts? CAR-T vs alloHCT in Post-Auto Relapse? What Cellular Therapies Will Be Available in the Next 5 yrs?
FEATURING
Sergio Giralt
- 28 views
- October 27, 2020
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Marginal Gastric Zone Lymphoma: The Role of Radiation Therapy
FEATURING
Joachim Yahalom
- 22 views
- October 18, 2019